The pharmaceutical industry demands intermediates of the highest caliber, where purity, consistency, and reliability are paramount. 4-Amino-2,6-dichlorophenol, identified by its CAS number 5930-28-9, is a distinguished organic intermediate that meets these stringent requirements, serving as a critical building block in the synthesis of numerous pharmaceutical compounds.

As a specialized manufacturer and supplier, NINGBO INNO PHARMCHEM CO.,LTD. understands the intricate needs of pharmaceutical R&D and manufacturing. 4-Amino-2,6-dichlorophenol, with its characteristic off-white crystalline form and an impressive assay of ≥99%, is precisely engineered to facilitate complex synthetic pathways. Its chemical structure (C6H5Cl2NO) and molecular weight (178.02) are well-defined, making it a predictable and reliable component in multi-step drug synthesis.

The importance of this intermediate extends across various therapeutic areas, where it is often employed in the creation of active pharmaceutical ingredients (APIs). Its incorporation into drug molecules can confer specific pharmacological properties, contributing to the efficacy and therapeutic outcomes of medications. For pharmaceutical companies looking to buy 4-Amino-2,6-dichlorophenol, ensuring a stable supply from a reputable source is key to maintaining uninterrupted production and research efforts.

When evaluating suppliers, it’s crucial to look beyond the basic CAS number and chemical name. Detailed specifications such as melting point (≥160℃) and minimal moisture content (≤1%) are indicators of quality. Moreover, understanding the manufacturing process and the supplier's commitment to quality control, often documented in a Certificate of Analysis (CoA), builds confidence. Sourcing from experienced manufacturers in China provides access to cost-effective solutions without compromising on quality.

For researchers and procurement specialists in the pharmaceutical sector, identifying a dependable supplier for intermediates like 4-Amino-2,6-dichlorophenol is a strategic advantage. It ensures that innovation can proceed without being hindered by raw material availability or quality issues. Partnering with suppliers who prioritize customer support, technical data, and timely delivery allows pharmaceutical companies to focus on their core mission: developing life-changing medicines.